Andrei V Krivtsov

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Acute Myeloid Leukemia

Top Venues

Science (New York, N.Y.)

Cancer discovery

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yadira M Soto-Feliciano, Francisco J Sánchez Rivera, Florian Perner, Douglas W Barrows, Edward R Kastenhuber, Yu-Jui Ho, Thomas S Carroll, Yijun Xiong, Disha Anand, Alexey A Soshnev, Leah A Gates, Mary Clare Beytagh, David Cheon, Shengqing Stan Gu, X Shirley Liu, Andrei V Krivtsov, Maximiliano Meneses, Elisa De Stanchina, Richard M Stone, Scott A Armstrong, Scott W Lowe, C David Allis
A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition. Cancer discovery (2022)
Matthew L Hemming, Morgan R Benson, Michael A Loycano, Justin A Anderson, Jessica L Andersen, Madeleine L Taddei, Andrei V Krivtsov, Brandon J Aubrey, Jevon A Cutler, Charles Hatton, Ewa Sicinska, Scott A Armstrong
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor. Cancer discovery 12 (7) (2022)
Steffen Boettcher, Peter Grant Miller, Rohan Sharma, Marie McConkey, Matthew Joseph Leventhal, Andrei V Krivtsov, Andrew O Giacomelli, Waihay J Wong, Jesi Kim, Sherry Chao, Kari J Kurppa, Xiaoping Yang, Kirsten Milenkowic, Frederica Piccioni, David E Root, Frank G Rücker, Yael Flamand, Donna S Neuberg, R Coleman Lindsley, Pasi A Jänne, William C Hahn, Tyler Jacks, Hartmut Döhner, Scott A Armstrong, Benjamin L Ebert
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science (New York, N.Y.) 365 (6453) (2020)
Hannah J Uckelmann, Stephanie M Kim, Eric M Wong, Charles Hatton, Hugh Giovinazzo, Jayant Y Gadrey, Andrei V Krivtsov, Frank G Rücker, Konstanze Döhner, Gerard M McGeehan, Ross L Levine, Lars Bullinger, George S Vassiliou, Scott A Armstrong
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. Science (New York, N.Y.) 367 (6477) (2020)
Olga A Guryanova, Kaitlyn Shank, Barbara Spitzer, Luisa Luciani, Richard P Koche, Francine E Garrett-Bakelman, Chezi Ganzel, Benjamin H Durham, Abhinita Mohanty, Gregor Hoermann, Sharon A Rivera, Alan G Chramiec, Elodie Pronier, Lennart Bastian, Matthew D Keller, Daniel Tovbin, Evangelia Loizou, Abby R Weinstein, Adriana Rodriguez Gonzalez, Yen K Lieu, Jacob M Rowe, Friederike Pastore, Anna Sophia McKenney, Andrei V Krivtsov, Wolfgang R Sperr, Justin R Cross, Christopher E Mason, Martin S Tallman, Maria E Arcila, Omar Abdel-Wahab, Scott A Armstrong, Stefan Kubicek, Philipp B Staber, Mithat Gönen, Elisabeth M Paietta, Ari M Melnick, Stephen D Nimer, Siddhartha Mukherjee, Ross L Levine
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nature medicine 22 (12) (2016)